SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Cantor Fitzgerald Reiterates Overweight on Arena Pharmaceuticals, Raises Price Target to $68

Cantor Fitzgerald analyst Alethia Young reiterates Arena Pharmaceuticals (NASDAQ:ARNA) with a Overweight and raises the price target from $56 to $68.

Benzinga · 05/08/2020 10:54

Cantor Fitzgerald analyst Alethia Young reiterates Arena Pharmaceuticals (NASDAQ:ARNA) with a Overweight and raises the price target from $56 to $68.